Gene, Cell, & RNA Therapy Landscape Report

The Gene, Cell, & RNA Therapy Landscape report, created in partnership with Citeline, is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.

Q1: Therapies approved in U.S., Canada, China

In Q1 2024:

  • a CAR-T therapy was approved for myeloma in China

  •  an AAV gene therapy was approved for hemophilia B in Canada

  • an autologous cell therapy was approved for melanoma in the U.S. 

Report Archives

2023 Archive

Read all the landscape reports from 2023.

2022 Archive

Read all the landscape reports from 2022.

2021 Archive

Read all the reports from 2021 here.


Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.